Development of a smartphone screening test for preclinical Alzheimer ’s disease and validation across the dementia continuum

Dementia prevalence is predicted to triple to 152 million globally by 2050. Alzheimer ’s disease (AD) constitutes 70% of cases. There is an urgent need to identify individuals with preclinical AD, a 10–20-year ...

Source: BMC Neurology - April 16, 2024 Category: Neurology Authors: Jane Alty, Lynette R. Goldberg, Eddy Roccati, Katherine Lawler, Quan Bai, Guan Huang, Aidan D Bindoff, Renjie Li, Xinyi Wang, Rebecca J. St George, Kaylee Rudd, Larissa Bartlett, Jessica M. Collins, Mimieveshiofuo Aiyede, Nadeeshani Fernando, Anju Bhagwat Tags: Study Protocol Source Type: research